TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11144866

Group type: EXPERIMENTAL
Intervention: Accurate feedback
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High performance
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low performance
Number of subjects: 40

Group type: COMPARATOR
Intervention: No exercise control
Number of subjects: 40
Study: 9126664

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pravastatin 20 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg and 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pravastatin 20 mg and 40 mg
Number of subjects: 0
Study: 31623184

Group type: EXPERIMENTAL
Intervention: Resistant Starch (RS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resistant Starch with high fiber (RSF)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Digestible Starch (DS)
Number of subjects: 18
Study: 30261980

Group type: EXPERIMENTAL
Intervention: Pictogram medals attached to inhalers in the intervention group
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group (no pictogram medals)
Number of subjects: 219
Study: 27142768

Group type: EXPERIMENTAL
Intervention: Figure-of-eight bandage
Number of subjects: 110

Group type: COMPARATOR
Intervention: Arm sling
Number of subjects: 110
Study: 24045343

Group type: EXPERIMENTAL
Intervention: Sham-treated study eyes
Number of subjects: 214

Group type: COMPARATOR
Intervention: Untreated fellow eyes with dry AMD
Number of subjects: 214
Study: 22578664

Group type: EXPERIMENTAL
Intervention: Humor therapy with professional performers (ElderClowns) and trained facility staff (LaughterBosses) for a minimum of nine two-hour sessions over 12 weeks.
Number of subjects: 398

Group type: COMPARATOR
Intervention: Usual care (control group) with no formal humor therapy.
Number of subjects: 398
Study: 19082329

Group type: EXPERIMENTAL
Intervention: Cardioplegia with procaine (Group B)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Cardioplegia without procaine (Group A)
Number of subjects: 18
Study: 16525815

Group type: EXPERIMENTAL
Intervention: 15 mg potassium bromide daily for 20 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 24 mg potassium bromide daily for 20 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 30 mg potassium bromide daily for 20 weeks
Number of subjects: 24
Study: 12720588

Group type: EXPERIMENTAL
Intervention: 3.5 g ALNA/d
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.44 g EPA+DHA/d
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.94 g EPA+DHA/d
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1.9 g EPA+DHA/d
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11256241

Group type: EXPERIMENTAL
Intervention: Valaciclovir 500 mg orally every 12 hours for 7 days
Number of subjects: 142

Group type: COMPARATOR
Intervention: Acyclovir 200 mg orally every 5 hours for 7 days
Number of subjects: 142
Study: 9403919

Group type: EXPERIMENTAL
Intervention: Relaxation training (6 sessions of progressive muscle relaxation and imagery)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control treatment (routine medical care)
Number of subjects: 22
Study: 8513908

Group type: COMPARATOR
Intervention: Intrathecal sufentanil (IS), 150 micrograms
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (IM), 50 micrograms kg‐1
Number of subjects: 36
Study: 2450187

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg orally) during a 6‐h infusion of aprotinin (2 x 10(6) KIU)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg sublingually)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31869478

Group type: EXPERIMENTAL
Intervention: Child Life preparation (minimum 15 minutes)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard practice without Child Life preparation (control)
Number of subjects: 59
Study: 29352306

Group type: EXPERIMENTAL
Intervention: Panitumumab plus GEMOX (P-GEMOX)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: EGFR amplification
Number of subjects: 57

Group type: COMPARATOR
Intervention: EGFR mutations (ECD and TKD)
Number of subjects: 57
Study: 26660279

Group type: EXPERIMENTAL
Intervention: GPi DBS
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: STN DBS
Number of subjects: 128
Study: 25572038

Group type: EXPERIMENTAL
Intervention: Tryptophan-rich dietary supplement from egg protein hydrolysate (0.5 g twice per day for 19 days)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (0.5 g twice per day for 19 days)
Number of subjects: 59
Study: 24325057

Group type: EXPERIMENTAL
Intervention: Laminoplasty combined Modified Buyang Huanwu Decoction (MBHD)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Laminoplasty
Number of subjects: 32
Study: 20600734

Group type: EXPERIMENTAL
Intervention: CM‐β‐CyD (carboxymethyl‐β‐cyclodextrin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SBE‐β‐CyD (sulfobutyl‐ether‐β‐cyclodextrin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plain drug tablets (FMT)
Number of subjects: 0
Study: 18803039

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 2474

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 2474
Study: 16845327

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Biochemotherapy
Number of subjects: 90
Study: 12627986

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study: 10857066

Group type: EXPERIMENTAL
Intervention: Low intensity pulsed ultrasound (frequency: 1.5 MHz, pulsed by 1 kHz, intensity: 30 mW/cm2, daily 20 minutes treatment)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard treatment (casting)
Number of subjects: 30
Study: 9165546

Group type: COMPARATOR
Intervention: Standard fixed dose of 500 mg/day of oral zidovudine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Concentration-controlled regimen of oral zidovudine
Number of subjects: 8
Study: 1587194

Group type: EXPERIMENTAL
Intervention: Ranitidine (mean 2150 mg/day, range 1200-3000 mg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Omeprazole (mean 33 mg/day, range 20-60 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (Basal evaluation)
Number of subjects: 12
Study: 2422479

Group type: EXPERIMENTAL
Intervention: 800 mg sulphinpyrazone (SP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 880 mg acetylsalicylic acid (ASA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30303707

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate, High-Fat diet with 15-min postmeal walks (LC+Ex)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate, High-Fat diet (LC)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Low-Fat Low-Glycemic Index diet (GL)
Number of subjects: 11
Study: 28934966

Group type: EXPERIMENTAL
Intervention: Interactive telerehabilitation intervention with home-based exercise training for 3 months
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Interactive telerehabilitation intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual aftercare programs
Number of subjects: 110
Study: 26302250

Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU) intervention
Number of subjects: 731

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 731
Study: 23709302

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 62

Group type: COMPARATOR
Intervention: Tramadol
Number of subjects: 62
Study: 21955862

Group type: EXPERIMENTAL
Intervention: Combination therapy (100 mg/day losartan after 40 mg/d enalapril for 4 months)
Number of subjects: 56

Group type: COMPARATOR
Intervention: ACEI monotherapy (40 mg/d enalapril for 4 months)
Number of subjects: 56
Study: 18439566

Group type: EXPERIMENTAL
Intervention: Eye bank predissected corneal grafts
Number of subjects: 40

Group type: COMPARATOR
Intervention: Surgeon-dissected corneal grafts
Number of subjects: 40
Study: 17319446

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14744276

Group type: EXPERIMENTAL
Intervention: High-dose eptifibatide (two 180-microg/kg single-dose boluses before CAS, then a 2.0-microg/kg/min infusion for 20-24 hours)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: High-dose eptifibatide
Number of subjects: 26
Study: 10653829

Group type: EXPERIMENTAL
Intervention: Immunoadsorption
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard medical therapy (control group)
Number of subjects: 34
Study: 9055135

Group type: EXPERIMENTAL
Intervention: 80 mg valsartan
Number of subjects: 129

Group type: COMPARATOR
Intervention: 10 mg lisinopril
Number of subjects: 129

Group type: COMPARATOR
Intervention: 25 mg hydrochlorothiazide
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Overall adverse experiences
Number of subjects: 129
Study: 8417172

Group type: EXPERIMENTAL
Intervention: Ribavirin 800 mg daily
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Ribavirin 600 mg daily
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Ribavirin 600 mg or 800 mg for 24 weeks
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 215
Study: 3712027

Group type: EXPERIMENTAL
Intervention: PRGR with trigeminal cisternography (50 cases)
Number of subjects: 100

Group type: COMPARATOR
Intervention: PRGR without trigeminal cisternography (50 cases)
Number of subjects: 100
Study: 31870421

Group type: EXPERIMENTAL
Intervention: Tailored psychological intervention (access to psychological treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (waitlist period of 6 months)
Number of subjects: 0
Study: 29225442

Group type: EXPERIMENTAL
Intervention: Faith-integrated (FI) intervention
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Secular (SEC) intervention
Number of subjects: 372

Group type: COMPARATOR
Intervention: Self-guided (SG) control
Number of subjects: 372
Study: 25481916

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT) patches plus behavioral support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Behavioral support alone
Number of subjects: 0
Study: 23708245

Group type: EXPERIMENTAL
Intervention: Cybele(®) Scagel
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 21852030

Group type: EXPERIMENTAL
Intervention: TEA intervention (n = 38)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control condition (n = 41)
Number of subjects: 79
Study: 19141765

Group type: EXPERIMENTAL
Intervention: High-DHA enteral feeds (approximately 1% total fatty acids)
Number of subjects: 657

Group type: COMPARATOR
Intervention: Standard DHA enteral feeds (approximately 0.3% total fatty acids)
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: High-DHA diet in girls
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: High-DHA diet in infants born weighing less than 1250 g
Number of subjects: 657

Group type: COMPARATOR
Intervention: Standard DHA in infants born weighing less than 1250 g
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: High-DHA diet in infants born weighing at least 1250 g
Number of subjects: 657

Group type: COMPARATOR
Intervention: Standard DHA in infants born weighing at least 1250 g
Number of subjects: 657
Study: 17295822

Group type: EXPERIMENTAL
Intervention: Virtual patients intervention group (14 simulated cases of abdominal pain over 7 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no access to software)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Virtual case exam (from intervention group)
Number of subjects: 48
Study: 15483282

Group type: COMPARATOR
Intervention: Reconstituted blood
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Fresh whole blood
Number of subjects: 200
Study: 11568065

Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration after cardiopulmonary bypass
Number of subjects: 573
Study: 9722217

Group type: EXPERIMENTAL
Intervention: Randomised clinical trials with adequate generation of allocation sequence
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Randomised clinical trials with adequate allocation concealment
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Randomised clinical trials allowing intention-to-treat analysis
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Double-blind randomised clinical trials
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Randomised clinical trials reporting sample-size calculations
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Crossover design trials
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Median number of subjects per intervention arm in parallel group trials
Number of subjects: 166
Study: 7920949

Group type: EXPERIMENTAL
Intervention: FISH (Fluorescence In Situ Hybridization)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PCR (Polymerase Chain Reaction)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: FISH
Number of subjects: 10
Study: 2968769

Group type: EXPERIMENTAL
Intervention: Salbutamol 0.3 mg (SAL)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Combination of Salbutamol 0.3 mg and Disodium Cromoglycate 3 mg (SAL + DSCG)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Disodium Cromoglycate 3 mg (DSCG)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ipratropium Bromide 80 ug (IB)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (peroral lactose pill)
Number of subjects: 7
Study: 31683491

Group type: EXPERIMENTAL
Intervention: Dry-electrode-based transcranial direct current stimulation (tDCS) at 2 mA for 20 minutes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dry-electrode-based transcranial direct current stimulation (tDCS)
Number of subjects: 60
Study: 30914064

Group type: EXPERIMENTAL
Intervention: Umeclidinium/vilanterol (UMEC/VI) 62.5/25 μg or 125/25 μg
Number of subjects: 3021

Group type: EXPERIMENTAL
Intervention: Umeclidinium (UMEC) 62.5 μg or 125 μg
Number of subjects: 3021

Group type: EXPERIMENTAL
Intervention: Vilanterol (VI) 25 μg
Number of subjects: 3021

Group type: EXPERIMENTAL
Intervention: All bronchodilators (UMEC/VI, UMEC, VI)
Number of subjects: 3021

Group type: EXPERIMENTAL
Intervention: Umeclidinium/vilanterol (UMEC/VI)
Number of subjects: 3021

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 3021
Study: 29126416

Group type: EXPERIMENTAL
Intervention: Physostigmine salicylate (Anticholium®) for up to 5 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.9% sodium chloride (placebo) for up to 5 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Physostigmine salicylate (Anticholium®)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.9% sodium chloride (placebo)
Number of subjects: 20
Study: 26447261

Group type: EXPERIMENTAL
Intervention: ED-based motivational intervention (20-30 minute motivational interview by a masters-prepared social worker and a follow-up reinforcement call)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control groups (not specified)
Number of subjects: 0
Study: 23336603

Group type: EXPERIMENTAL
Intervention: Multi-component school-based intervention with a part-time physical activity consultant
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (5 schools not receiving the intervention)
Number of subjects: 10
Study: 21931767

Group type: EXPERIMENTAL
Intervention: 10-Hz STN-DBS
Number of subjects: 12

Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: ≥ 130-Hz STN-DBS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Milliseconds timing
Number of subjects: 12
Study: 19031126

Group type: EXPERIMENTAL
Intervention: PPH1 group (standard PPH operation)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: PPH2 group (PPH and external hemorrhoids excision)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Milligan‐Morgan group (Milligan‐Morgan hemorrhoidectomy)
Number of subjects: 112
Study: 17070158

Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 798

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 798
Study: 12830440

Group type: EXPERIMENTAL
Intervention: Daily HD
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Nocturnal HD
Number of subjects: 23

Group type: COMPARATOR
Intervention: Conventional HD (Control)
Number of subjects: 23
Study: 10752810

Group type: EXPERIMENTAL
Intervention: Carbamezapine (CBZ) 100 mg every 8 hours
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carbamezapine (CBZ)
Number of subjects: 12
Study: 15328635

Group type: EXPERIMENTAL
Intervention: Intraoperative application of 50 mg 5‐FU (Group A)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Postoperative subconjunctival injections of 5 mg 5‐FU (Group B)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intra and postoperative administration of 5‐FU (Group C)
Number of subjects: 36
Study: 8482191

Group type: EXPERIMENTAL
Intervention: Lactitol
Number of subjects: 4

Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 4
Study: 6743990

Group type: EXPERIMENTAL
Intervention: Side-to-side A-V fistula
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: End-to-side A-V fistula
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Peroperative measurements of fistula flow
Number of subjects: 71
Study: 29781394

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy with Relaxation (CBT + R)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy with Imagery Rescripting (CBT + ImRs)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Moderated Self-Help Group (SH)
Number of subjects: 180
Study: 28549015

Group type: EXPERIMENTAL
Intervention: Early oral feeding (EOF) on the first postoperative day
Number of subjects: 280

Group type: COMPARATOR
Intervention: Late oral feeding (LOF) 7 days after surgery
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Early oral feeding (EOF)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Late oral feeding (LOF)
Number of subjects: 280
Study: 25997842

Group type: EXPERIMENTAL
Intervention: Self-distancing (third person perspective)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Self-distancing (exemplar perspective, e.g., Batman)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no self-distancing)
Number of subjects: 96
Study: 23915290

Group type: EXPERIMENTAL
Intervention: Incredible Years parent training enhanced with home visits
Number of subjects: 133

Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 133
Study: 20479444

Group type: EXPERIMENTAL
Intervention: TheraGauze
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TheraGauze + becaplermin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline-moistened gauze + becaplermin (historical data)
Number of subjects: 0
Study: 15664716

Group type: EXPERIMENTAL
Intervention: 15 mg/70 kg d-amphetamine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 7.5 mg/70 kg d-amphetamine
Number of subjects: 22

Group type: COMPARATOR
Intervention: 0 mg/70 kg (placebo)
Number of subjects: 22
Study: 11468472

Group type: EXPERIMENTAL
Intervention: Intramedullary corticocancellous bone plug (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Austin Moore hemiarthroplasty alone (group B)
Number of subjects: 60
Study: 9710164

Group type: EXPERIMENTAL
Intervention: 10-week muscle strength training program of the upper extremities
Number of subjects: 16
Study: 7976644

Group type: EXPERIMENTAL
Intervention: Propofol (mean rate 232 mg/h, range 150‐400 mg/h)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Morphine (mean rate 2.3 mg/h, range 0‐4 mg/h)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Midazolam (mean rate 2.8 mg/h, range 0‐5 mg/h)
Number of subjects: 15
Study: 2499466

Group type: EXPERIMENTAL
Intervention: Multiple insulin injections (MII)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 20
Study: 1095246

Group type: EXPERIMENTAL
Intervention: Intranasal beclomethasone dipropionate aerosol (400 mug/day)
Number of subjects: 35
Study: 27872387

Group type: EXPERIMENTAL
Intervention: Higher cancer worry
Number of subjects: 2154

Group type: EXPERIMENTAL
Intervention: Greater perceived risk
Number of subjects: 2154

Group type: COMPARATOR
Intervention: Cancer worry
Number of subjects: 2154
Study: 28051240

Group type: EXPERIMENTAL
Intervention: Combined therapy of montelukast, azithromycin and bronchodilators or glucocorticoid
Number of subjects: 96

Group type: COMPARATOR
Intervention: Combined therapy using azithromycin and bronchodilators or glucocorticoid
Number of subjects: 96
Study: 24579084

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no fish oil)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypocaloric diet
Number of subjects: 0
Study: 22718792

Group type: EXPERIMENTAL
Intervention: Deep anterior lamellar keratoplasty (DALK)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Penetrating keratoplasty (PK)
Number of subjects: 140
Study: 20348361

Group type: EXPERIMENTAL
Intervention: Clown intervention (children accompanied by parents and clowns)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (children accompanied by parents without clowns)
Number of subjects: 70
Study: 18454213

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with fentanyl
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous fentanyl
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 15837236

Group type: EXPERIMENTAL
Intervention: ACAM2000 (highest dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dryvax
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACAM2000 (dilution doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACAM2000 and Dryvax (adverse events)
Number of subjects: 0
Study: 12888057

Group type: EXPERIMENTAL
Intervention: Microkeratome incision followed by laser ablation
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control eyes (conventional LASIK treatment)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Both study and control eyes post-laser ablation
Number of subjects: 17
Study: 10454950

Group type: EXPERIMENTAL
Intervention: Sulfonylureas, Metformin, or Insulin
Number of subjects: 0
Study: 8730222

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0